DESFERRIOXAMINE OTOTOXICITY - EVALUATION OF RISK-FACTORS IN THALASSEMIC PATIENTS AND GUIDELINES FOR SAFE DOSAGE

被引：128

作者：

PORTER, JB ^{[1
]}

JASWON, MS ^{[1
]}

HUEHNS, ER ^{[1
]}

EAST, CA ^{[1
]}

HAZELL, JWP ^{[1
]}

机构：

[1] ROYAL EAR HOSP,DEPT OTOLARYNGOL,LONDON WC1E 6AU,ENGLAND

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 1989年 / 73卷 / 03期

关键词：

D O I：

10.1111/j.1365-2141.1989.tb07761.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：403 / 409

页数：7

共 26 条

[1] DESFERRIOXAMINE ADMINISTERED INTRAVENOUSLY BY INFUSION CAUSES A REDUCTION IN THE ELECTRORETINOGRAM IN RABBITS ANESTHETIZED WITH URETHANE [J].

ARDEN, GB .

HUMAN TOXICOLOGY, 1986, 5 (04) :229-236

[2] OCULAR CHANGES IN PATIENTS UNDERGOING LONG-TERM DESFERRIOXAMINE TREATMENT [J].

ARDEN, GB ;

WONKE, B ;

KENNEDY, C ;

HUEHNS, ER .

BRITISH JOURNAL OF OPHTHALMOLOGY, 1984, 68 (12) :873-877

[3] LONG-TERM CHELATION THERAPY IN THALASSEMIA MAJOR - EFFECT ON LIVER IRON CONCENTRATION, LIVER HISTOLOGY, AND CLINICAL PROGRESS [J].

BARRY, M ;

FLYNN, DM ;

LETSKY, EA ;

RISDON, RA .

BMJ-BRITISH MEDICAL JOURNAL, 1974, 2 (5909) :16-20

[4]

BLAKE DR, 1985, Q J MED, V56, P345

[5]

BORGNAPIGNATTI C, 1984, LANCET, V1, P681

[6]

DAVIES SC, 1983, LANCET, V2, P181

[7] AUDITORY INVOLVEMENT IN THALASSEMIA MAJOR [J].

DEVIRGILIIS, S ;

ARGIOLU, F ;

SANNA, G ;

CORNACCHIA, G ;

COSSU, P ;

CAO, A ;

MALLARDI, V ;

PUXEDDU, P .

ACTA HAEMATOLOGICA, 1979, 61 (04) :209-215

[8]

GUERIN A, 1985, LANCET, V2, P39

[9]

HAZRLL JWP, 1976, J LARYNGOL OTOL, V90, P877

[10] DRUG TOXICITY OF THE INNER-EAR [J].

HYBELS, RL .

MEDICAL CLINICS OF NORTH AMERICA, 1979, 63 (02) :309-319

← 1 2 3 →